UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~Washington~~WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

~~the~~Date ~~Securities~~of ~~Exchange~~Report ~~Act~~(Date of ~~1934~~earliest event reported): September 13, 2007

Date of Report (Date of earliest event reported): June 8, 2007

MICROMED CARDIOVASCULAR, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-51487	90-0265161
DELAWARE	000-51487	98-0228169
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S. Employer Identification Number)

8965 Interchange Drive Houston, Texas		77054
(Address of principal executive offices)		(Zip Code)

8965 Interchange Drive

~~Registrant’s telephone number~~Houston, ~~including~~Texas ~~area~~77054 ~~code: (713) 838-9210~~

(Address of principal executive offices) (Zip Code)

(713) 838-9210

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

~~(b)~~ On ~~June~~September 813, 2007, ~~Juliet~~the ~~Markovich~~company ~~tendered~~entered ~~her~~into ~~resignation~~an asagreement ~~chief~~with ~~financial~~Agility ~~officer~~Business ~~of MicroMed Cardiovascular~~Partners, ~~Inc.~~LLC, pursuant to which Deanne Yartz will serve as the company’s Chief Financial Officer effective ~~June~~October 208, 2007. Since 2003, Ms. Yartz served as a financial consultant with Sirius Solutions, LLP. From 1998 to 2003, Ms. Yartz was an ~~pursue~~independent ~~another~~consultant ~~employment~~for ~~opportunity~~various private and publicly traded companies. ~~The~~Prior ~~resignation~~to that, Ms. Yartz was ~~not~~the ~~related~~VP toof ~~any~~Finance ~~disagreement~~and ~~between~~Chief Financial Officer of WNS, Inc., from 1986 to 1998. Ms. Yartz ~~Markovich~~holds ~~and~~a BBA degree from the ~~Company~~University of Texas and is a Certified Public Accountant. Ms. Yartz has not been involved with a related transaction or relationship as defined by Item 404(a) of Regulation S-B.

~~SIGNATURE~~SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MICROMED CARDIOVASCULAR, INC.
Date: June 13, 2007	By:	/s/ Juliet Markovich
		Juliet Markovich
		Chief Financial Officer
		(Duly Appointed Officer)

MICROMED CARDIOVASCULAR, INC.

(Registrant)

/s/ ROBERT BENKOWSKI

Robert Benkowski,

Chief Executive Officer

DATE: September 19, 2007

Filing Compare · MICROMED CARDIOVASCULAR INC